Seven health systems have invested in a $26 million funding round for Optain Health, which uses AI to detect eye disease.
The oversubscribed series A investment included Houston-based Memorial Hermann Health System, New Hyde Park, N.Y.-based Northwell Health, Winston-Salem, N.C.-based Novant Health, Columbus-based Ohio State University Wexner Medical Center, and Pittsburgh-based UPMC.
Optain was cofounded by venture capital firm Aegis Ventures, which works with a consortium of 11 health systems to codevelop healthcare AI startups. The company created a portable robotic camera to detect eye conditions, such as glaucoma and diabetic retinopathy, and evaluate cardiovascular disease risk in real time without pupil dilation.
“By deploying Optain in patient care and investing in the company, consortium members have shown strong confidence in its value for enabling early detection and better outcomes,” said John Noseworthy, MD, chair of the Aegis Digital Consortium and emeritus CEO of Rochester, Minn.-based Mayo Clinic, in a Sept. 10 news release. Dr. Noseworthy will represent the health systems as an observer on the startup’s board.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
